TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 226 filers reported holding TG THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,185,280 | -69.9% | 141,780 | -10.7% | 0.00% | -75.0% |
Q2 2023 | $3,943,300 | +445.4% | 158,748 | +630.9% | 0.00% | +300.0% |
Q3 2021 | $723,000 | -57.8% | 21,720 | -50.8% | 0.00% | -50.0% |
Q2 2021 | $1,712,000 | -55.5% | 44,124 | -44.7% | 0.00% | -60.0% |
Q1 2021 | $3,845,000 | +0.0% | 79,780 | +8.0% | 0.01% | 0.0% |
Q4 2020 | $3,844,000 | +75.9% | 73,894 | -9.5% | 0.01% | +66.7% |
Q3 2020 | $2,185,000 | +3.7% | 81,670 | -24.5% | 0.00% | -25.0% |
Q2 2020 | $2,108,000 | – | 108,210 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |